Beard Bros Pharms

Tripper Advisor: The Rise of Kanna in Modern Ethnobotanical Markets

Dennis Walker
03 October 2025

In a world where people are becoming increasingly aware of the broad biodiversity of consciousness altering plants and fungi, a “choose your own adventure” playbook for enhancing well-being and stoking stimuli in the human brain is more available than ever thanks to the global market. Today, we’re journeying to South

Wisconsin’s New Push for Medical Marijuana Legalization

Beard Bros Media
03 October 2025

Republican lawmakers in Wisconsin have introduced new legislation to legalize medical marijuana, reigniting a long-standing debate within the state. This latest effort, announced on September 29, 2025, aims to create a pathway for patients with serious health conditions to access medical cannabis legally. While the full text of the new

The Great Cannabis Reclassification Debate: Who Really Wins?

Xylem Robotics
03 October 2025

Cannabis policy has long been framed as a binary choice: reschedule or deschedule. The reality is more complicated. Cannabis is both a consumer product and a therapeutic aid, and forcing it into a single regulatory lane oversimplifies how people actually use and incorporate it into their lives. President Donald Trump

Faced With Billions of Dollars of Debts Owed, Cannabis Operators Finally Have a Smart Solution

Beard Bros Media
02 October 2025

What if we told you that there is currently over $4 billion held up in outstanding accounts receivable/accounts payable in today’s regulated cannabis markets here in the U.S.? That’s Billion, with a B, and that’s a lot of money that has yet to make it to the hands of the

Germany’s First Report on Cannabis Legalization Finds Opponents’ Fears Unfounded

Beard Bros Media
02 October 2025

When Germany's cannabis legalization was introduced in April 2024, critics voiced concerns about higher youth consumption, more traffic accidents, and potential public health risks. However, nearly a year later, a detailed government report shows these fears were largely unfounded, providing important lessons for other countries exploring similar reforms. The interim